Novo Nordisk Launches Wegovy at Pharmacies Nationwide
Novo Nordisk launched the first GLP-1 weight-loss pill on Monday with a pledge that manufacturing investments will enable it to avoid the type of shortages that plagued the rollout of its injectable version.
The company said doctors can now prescribe the new oral version of Wegovy and patients can pick it up at more than 70,000 pharmacies and via mail-order services throughout the country.
The starting dose of the once-daily pill costs $150 a month for patients without insurance coverage, while the largest dose — on which patients lose the most weight — will be available by the end of the week for $300 a month. For those with employer insurance coverage, the company says it will cost as little as $25 a month.
Please select this link to read the complete article from The Washington Post.